Ensysce Biosciences (ENSC) Misses Q2 EPS by 79c

Ensysce Biosciences (NASDAQ: ENSC) reported Q2 EPS of ($0.79). Revenue for the quarter came in at $1.37 million.

For earnings history and earnings-related data on Ensysce Biosciences (ENSC) click here.

You May Also Be Interested In

• Trump: Witkoff And Kushner Had Productive Meeting With Iran
• Grab Holdings (GRAB) call put ratio 7.2 calls to 1 put with a focus on November 4 and April 6 calls, share price up 8.2%
• CRH plc (CRH) 1700 contracts of October 95 calls trade